A Win For Checkpoint Therapeutics, Inc.
Mon, Mar 10, 2025 at 08:11 PM
Checkpoint Therapeutics, Inc. (CKPT:NASDAQ) jumped higher at $3.98, a gain of 61.1%. On Mon, Mar 10, 2025, CKPT:NASDAQ hit a New 2-Week High of $3.98. The stock appeared on our News Catalysts scanner on Mon, Mar 10, 2025 at 01:55 PM in the 'ACQUISITION' category. From Mon, Feb 24, 2025, the stock recorded 40.00% Up Days and 27.27% Green Days
The stock spiked on Wed, Dec 18, 2024 at $4.44 with a volume of 5M+.
About Checkpoint Therapeutics, Inc. (CKPT:NASDAQ)
Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company which focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers.
Top 10 Gainers:
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 176.92%
- Heidmar Maritime Holdings Corp. (HMR:NASDAQ), 69.54%
- Redfin Corporation (RDFN:NASDAQ), 67.87%
- Checkpoint Therapeutics, Inc. (CKPT:NASDAQ), 61.13%
- Sharps Technology Inc. (STSS:NASDAQ), 48.3%
- Protagonist Therapeutics, Inc. (PTGX:NASDAQ), 45.89%
- Bally's Corporation (BALY:NYSE), 42.74%
- Mineralys Therapeutics Inc. (MLYS:NASDAQ), 42.21%
- Trevi Therapeutics, Inc. (TRVI:NASDAQ), 41.16%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 39.5%